You are here
Novo Nordisk aims to be ahead of the pharma pack with Iran investment
DANISH drugmaker Novo Nordisk, the world's top insulin supplier, expects to be ahead of the pack now nuclear sanctions are lifted in Iran, thanks to a continuous presence and a pre-emptive investment plan.
The country is an attractive target for Big Pharma seeking to sell new
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org